Perrigo Company plc (PRGO) Reports $1.06B Q2 Sales, Advances ‘Three-S’ Strategy
Perrigo Company plc (PRGO) has announced its second-quarter sales reached $1.06 billion, demonstrating continued progress in its "Three-S" strategy focused on Supply Chain, Structure, and Strategy. The company has also achieved significant milestones, including the successful completion of the U.S. launch of Opill and the full integration of its previously acquired HRA Pharma acquisition. These achievements are bolstering the company's position in the self-care market.
http://www.msn.com/en-us/money/savingandinvesting/perrigo-company-plc-prgo-reports-1-06b-q2-sales-advances-three-s-strategy/ar-AA1MPjh1?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1